stocksbrew
Market
Explore
Watchlist
Market
Explore
Watchlist
stocksbrew.

Analyse any US stock, then track the ones you care about.

Appearance

Product

  • Market today
  • Explore
  • Watchlist
  • Earnings
  • US stocks
  • AI agent access

Free tools

  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Use cases
  • Developer API

Company

  • About
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchLaunched on FazierStocksBrew - Featured on Startup FameFeatured on Wired Business
PF
PFE stock logo

Pfizer Inc.

Large Cap · Healthcare · Drug Manufacturers - General

$27.81−$0.43 (-1.51%)
PF
PFE stock logo

Pfizer Inc.

Large Cap · Healthcare · Drug Manufacturers - General

$27.81−$0.43 (-1.51%)

Stock analysis

$27.81−$0.43 (-1.51%)

Get the AI take on PFE

Track it to unlock the price chart, verdict and what could change it.

  • ✓Live price chart
  • ✓A clear accumulate, trim or avoid call

Free to track. No card required.

Stock Fundamentals & Key Indicators

52-week range
Low$23.11
High$28.75
Today $27.81
RSI (14)
77.0Overbought
03070100

Overall score

43/100

See the full financial picture

Open the five-year record, valuation checks and Wall Street view behind these scores.

  • ✓5 years of revenue, profit and cash flow
  • ✓Valuation and balance-sheet checks
  • ✓Business and geographic mix
  • ✓Analyst targets and recommendation trend

Free for 3 days, then $9/mo. Cancel anytime.

Analyst Rating and Sentiment

Analyst price targets

Lowest

$25

Current price

$27.81

Median target

$28

Highest

$35.75

LowHigh

Operating Record

Revenue

What's working

  • Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
  • Price / sales: You're paying a modest amount for each dollar of revenue coming in.

What to watch

  • Debt exceeds cash by $51.8B, increasing balance-sheet pressure, a warning sign.

What the market charges

Forward P/E

Favorable · 52% below avg

9.67x

Price / sales

Strong · Priced modestly against the revenue it brings in

2.40x

Price / FCF

Strong · Priced well within what its cash flow supports

13.90x

EV / EBITDA

Strong · Operating earnings comfortably support this price

8.06x

How efficiently it compounds

ROIC

Reasonable · A middling return on the capital it puts to work

13.5%

ROE

Middle ground · Mixed

5.0%

Debt / equity

Favorable · 0.72 - solid leverage

0.74x

Current ratio

Reasonable · Just enough on hand to cover near-term bills

1.27x

Peer Comparison

CompanyMkt capP/ERev growthScore
PF
PFE stock logo
PFEPfizer Inc.
$152.69B35.5-0.2%43
GM
GMED stock logo
GMEDGlobus Medical
$11.53B22.0+19.7%78
IN
INDV stock logo
INDVIndivior
$4.60B13.9+13.5%77
DX
DXCM stock logo
DXCMDexcom
$33.87B35.4+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.11T40.1+49.6%76

What is moving PFE

News

4 stories · 7d · PFE
  • PL
    PLTR stock logo
    AM
    AMD stock logo
    PF
    PFE stock logo
    13h ago · Shopify Inc. via Seeking Alpha

    Shopify attracts a new bull as Rosenblatt launches coverage

    Mixed
  • MR
    MRK stock logo
    AM
    AMGN stock logo
    PF
    PFE stock logo
    1d ago · Pfizer Inc. via Yahoo Finance

    Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen?

    Mixed
  • EL
    EL stock logo
    PF
    PFE stock logo
    NO
    NOW stock logo
    1d ago · Pfizer Inc. via Nasdaq

    Notable Wednesday Option Activity: EL, PFE, NOW

    Mixed
  • CA
    CAST stock logo
    MR
    MRNA stock logo
    SK
    SKDD stock logo
    1d ago · Moderna Inc. via Nasdaq

    Pre-Market Most Active for Aug 19, 2026 : CAST, MRNA, SKDD, SKHY, SKUU, MUU, NOK, MRK, STLA, LYG, NIO, PFE

    Mixed
All market news→